Citius Oncology, Inc.

CTOR · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$0$0$0$0
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$17,209$15,339$14,381$8,269
Other Curr. Assets$1,100$2,700$2,700$2,700
Total Curr. Assets$18,309$18,039$17,081$10,969
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$73,400$73,400$73,400$73,400
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$73,400$73,400$73,400$73,400
Other Assets$0$0$0$0
Total Assets$91,709$91,439$90,481$84,369
Liabilities
Payables$8,667$7,676$5,875$3,712
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$44,323$42,064$37,525$28,989
Total Curr. Liab.$52,990$49,740$43,400$32,700
LT Debt$3,800$3,800$3,800$3,800
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,521$2,256$1,992$1,728
Other NC Liab.$0$0$0$0
Total NC Liab.$6,321$6,057$5,792$5,528
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$3,800
Total Liabilities$59,311$55,797$49,192$38,229
Equity
Pref Stock$0$0$0$0
Common Stock$7$7$7$7
Retained Earnings-$59,043-$53,673-$45,938-$39,279
AOCI$0$0$0$0
Other Equity$91,434$89,309$87,220$85,412
Total Equity$32,398$35,643$41,290$46,140
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$91,709$91,439$90,481$84,369
Net Debt$3,800$3,800$3,800$3,800